Post-TURBT Bladder Instillation in Korea
Treatment Overview Post-TURBT bladder instillation is an intravesical therapy administered immediately after a transurethral resection of bladder tumor (TURBT) procedure to prevent recurrence of non-muscle
Experience World-Class Beauty & Medical Care in Korea
Bladder Health & Surgery
Search Your Need
Filter A_Z
News latter
Bladder Health & Surgery
Ensure optimal bladder function with Korea’s top urology clinics specializing in bladder health and surgical care. From minimally invasive procedures for bladder stones and tumors to advanced treatments for incontinence and urinary tract disorders, Korean specialists combine precision technology with patient-centered care. Korea Beauty Guide connects international patients with trusted experts who provide safe, effective, and personalized solutions for lasting bladder wellness.
Search Your Treatments with A-Z Latter Filter
Low-Dose Bladder Instillation Therapy in Korea
Treatment Overview Low-dose bladder instillation therapy is a targeted treatment for non-muscle invasive bladder cancer (NMIBC) in which lower concentrations of chemotherapeutic or immunotherapeutic agents,
High-Dose Bladder Instillation Therapy in Korea
Treatment Overview High-dose bladder instillation therapy is an advanced treatment for non-muscle invasive bladder cancer (NMIBC) in which higher concentrations of chemotherapeutic or immunotherapeutic agents,
Induction BCG Therapy in Korea
Treatment Overview Induction BCG (Bacillus Calmette-Guérin) therapy is the initial phase of immunotherapy for non-muscle invasive bladder cancer (NMIBC). It involves delivering BCG, a weakened
Maintenance BCG Therapy in Korea
Treatment Overview Maintenance BCG (Bacillus Calmette-Guérin) therapy is an advanced immunotherapy for non-muscle invasive bladder cancer (NMIBC) that follows initial BCG induction therapy. This approach
Sequential Intravesical Therapy in Korea
Treatment Overview Sequential intravesical therapy is an advanced treatment strategy for non-muscle invasive bladder cancer (NMIBC) in which patients receive a combination of different intravesical
Epirubicin Bladder Instillation in Korea
Treatment Overview Epirubicin bladder instillation is a targeted intravesical chemotherapy treatment for non-muscle invasive bladder cancer (NMIBC). The chemotherapeutic agent epirubicin is delivered directly into
Doxorubicin Intravesical Therapy in Korea
Treatment Overview Doxorubicin intravesical therapy is an effective localized chemotherapy treatment for non-muscle invasive bladder cancer (NMIBC). In this procedure, doxorubicin, a potent anti-cancer drug,
Gemcitabine Bladder Instillation in Korea
Treatment Overview Gemcitabine bladder instillation is an advanced intravesical chemotherapy treatment used to manage non-muscle invasive bladder cancer (NMIBC), especially for patients who are unresponsive
Mitomycin C Bladder Instillation in Korea
Treatment Overview Mitomycin C bladder instillation is a targeted intravesical chemotherapy treatment used for non-muscle invasive bladder cancer (NMIBC). In this procedure, the anti-cancer drug
Post-TURBT Bladder Instillation in Korea
Treatment Overview Post-TURBT bladder instillation is an intravesical therapy administered immediately after a transurethral resection of bladder tumor (TURBT) procedure to prevent recurrence of non-muscle
Low-Dose Bladder Instillation Therapy in Korea
Treatment Overview Low-dose bladder instillation therapy is a targeted treatment for non-muscle invasive bladder cancer (NMIBC) in which lower concentrations of chemotherapeutic or immunotherapeutic agents,
High-Dose Bladder Instillation Therapy in Korea
Treatment Overview High-dose bladder instillation therapy is an advanced treatment for non-muscle invasive bladder cancer (NMIBC) in which higher concentrations of chemotherapeutic or immunotherapeutic agents,
Induction BCG Therapy in Korea
Treatment Overview Induction BCG (Bacillus Calmette-Guérin) therapy is the initial phase of immunotherapy for non-muscle invasive bladder cancer (NMIBC). It involves delivering BCG, a weakened
Maintenance BCG Therapy in Korea
Treatment Overview Maintenance BCG (Bacillus Calmette-Guérin) therapy is an advanced immunotherapy for non-muscle invasive bladder cancer (NMIBC) that follows initial BCG induction therapy. This approach
Sequential Intravesical Therapy in Korea
Treatment Overview Sequential intravesical therapy is an advanced treatment strategy for non-muscle invasive bladder cancer (NMIBC) in which patients receive a combination of different intravesical
Epirubicin Bladder Instillation in Korea
Treatment Overview Epirubicin bladder instillation is a targeted intravesical chemotherapy treatment for non-muscle invasive bladder cancer (NMIBC). The chemotherapeutic agent epirubicin is delivered directly into
Doxorubicin Intravesical Therapy in Korea
Treatment Overview Doxorubicin intravesical therapy is an effective localized chemotherapy treatment for non-muscle invasive bladder cancer (NMIBC). In this procedure, doxorubicin, a potent anti-cancer drug,
Gemcitabine Bladder Instillation in Korea
Treatment Overview Gemcitabine bladder instillation is an advanced intravesical chemotherapy treatment used to manage non-muscle invasive bladder cancer (NMIBC), especially for patients who are unresponsive
Mitomycin C Bladder Instillation in Korea
Treatment Overview Mitomycin C bladder instillation is a targeted intravesical chemotherapy treatment used for non-muscle invasive bladder cancer (NMIBC). In this procedure, the anti-cancer drug